Overview

Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids

Status:
Completed

Trial end date:
2008-03-01

Target enrollment:

Participant gender:

Summary

To compare the safety and efficacy of cyclosporine (CsA) + mycophenolate mofetil (MMF) + corticosteroids © to CsA + Rapamune + Cs with CsA elimination in the Rapamune arm with the introduction of MMF in de novo renal allograft recipients.

Phase:

Phase 4

Details

Lead Sponsor:

Pfizer

Treatments:

Everolimus
Sirolimus